SCHEMBL27870348

SCHEMBL27870348

CC(C=O)c1ncc(Nc2c(F)cccc2C(F)(F)F)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.39
JAK1 P23458 2/20 0.36
JAK3 P52333 2/20 0.36
JAK2 O60674 2/20 0.36
MAPK10 P53779 2/20 0.35
FGFR4 P22455 1/20 0.33
CTSS P25774 2/20 0.33
MAP4K1 Q92918 1/20 0.31
CYP2C9 P11712 1/20 0.31
MAPK8 P45983 1/20 0.31
MAPK9 P45984 1/20 0.31
KCNH2 Q12809 1/20 0.31
MAPK14 Q16539 1/20 0.31
EGFR P00533 2/20 0.31
MAPT P10636 1/20 0.31
DHODH Q02127 2/20 0.31
CDK8 P49336 1/20 0.31
SLC22A12 Q96S37 1/20 0.31
BTK Q06187 1/20 0.31
SYK P43405 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27870347 0.84 PTGS2 (0.44) PTGS2JAK1JAK3JAK2MAPK10
Hydrochloric Acid SCHEMBL2807566 0.84 PTGS2 (0.38) PTGS2JAK1JAK3JAK2MAPK10
SCHEMBL27870364 0.83 PTGS2 (0.37) PTGS2JAK1JAK3JAK2MAPK10
SCHEMBL28797574 0.77 PTGS2 (0.38) PTGS2JAK1JAK3JAK2MAPK10
SCHEMBL2811243 0.76 BDKRB1 (0.40) PTGS2JAK1JAK3JAK2MAPK10
SCHEMBL14856644 0.76 PTGS2 (0.39) PTGS2JAK1JAK3JAK2MAPK10
SCHEMBL2782296 0.75 PTGS2 (0.44) PTGS2JAK1JAK3JAK2MAPK10
SCHEMBL185749 0.75 PTGS2 (0.40) PTGS2JAK1JAK3JAK2MAPK10
Hydrochloric Acid SCHEMBL2811611 0.74 PTGS2 (0.39) PTGS2JAK1JAK3JAK2MAPK10
SCHEMBL2808238 0.74 BDKRB1 (0.47) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102414177-A Compounds as bradykinin b1 antagonists BOEHRINGER INGELHEIM INT 2012-04-11 CN disclosed